NIH-funded research R01 grant

MRI and AI to personalize deep brain stimulation for Parkinson's

Official title: Functional Magnetic Resonance Imaging and Deep Learning to Improve Deep Brain Stimulation Therapy

Funded at Ge Medical Systems Information Technologies, INC · NIH-11263609 · Data updated 2026-11-12

This project uses brain MRI and artificial intelligence to help personalize deep brain stimulation settings so people with Parkinson's get faster, safer symptom relief.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionGe Medical Systems Information Technologies, INC
NIH-funded
Lab location1 site (Niskayuna, United States)
Project startSeptember 19, 2023
Project endNovember 30, 2028
Funding year2026
Award (this year)$326,433
NIH project number5R01NS133433-04
Project IDNIH-11263609 on NIH RePORTER

Who could benefit from this research

Could help

People with Parkinson's disease or other movement disorders who are candidates for, or already have, deep brain stimulation implants and can undergo MRI and follow-up programming visits.

Less likely to help

Patients who are not DBS candidates, cannot safely have MRI (for example, because of incompatible hardware), or have severe cognitive or medical issues preventing participation are unlikely to benefit directly.

What this research studies

You would get functional MRI scans to map brain activity and have your DBS device settings and clinical responses recorded. Researchers will apply deep learning (AI) to the imaging and outcome data to predict better stimulation parameters. The work targets both older four-contact DBS leads and newer multi-contact directional leads so stimulation can hit smaller brain areas and avoid side effects. The aim is to shorten the months-long trial-and-error tuning process, reduce clinic visits, and improve symptom control.

Why it matters

Potential benefit: If successful, this could cut the time and number of visits needed to find effective DBS settings and reduce stimulation-related side effects.

How similar studies have gone: Some prior imaging- and AI-based approaches to guide DBS programming have shown promise, but combining functional MRI with deep learning for routine clinical tuning is relatively new.

Where this research is happening

  • Ge Medical Systems Information Technologies, INC
    Niskayuna, United States
    Active

Researchers

  • Principal investigator: Ajala, Afis — Ge Medical Systems Information Technologies, INC
  • Study coordinator: Ajala, Afis

Related research

Other NIH-funded projects on the same topics.

  • Improving deep brain stimulation with MRI and AI

    We use brain scans and artificial intelligence to speed up and personalize deep brain stimulation settings for people getting DBS.

    NIH research Ge Medical Systems Information Technologies, INC · Niskayuna, United States · NIH-11478774

  • Using advanced imaging and AI to enhance deep brain stimulation for better treatment outcomes

    This study is looking to make deep brain stimulation therapy for Parkinson's disease quicker and easier by using advanced brain imaging and smart technology, so patients can find the best treatment settings faster and with less hassle.

    NIH research Ge Medical Systems Information Technologies, INC · Niskayuna, United States · NIH-10930962

  • Understanding heart fibrosis with AI, MRI, and genomics

    A doctor-scientist is using artificial intelligence, advanced heart MRI, and genetic data to learn how scar tissue forms in the aging heart and how to prevent it.

    NIH research Brigham and Women's Hospital · Boston, United States · NIH-11381731

  • Improving MRI safety for patients with deep brain stimulators

    This study is working to make MRI scans safer for people with deep brain stimulation devices, so they can get the imaging they need without worrying about their implants, helping doctors better understand their health and treatment.

    NIH research University of Minnesota · Minneapolis, United States · NIH-10893365

  • Integrative histo-genomic analysis to guide cancer risk and targeted therapies with interpretable AI

    Researchers are developing an advanced AI-powered approach to map genetic and cellular patterns across breast and cervical cancers to help tailor treatments.

    NIH research Tuskegee University · Tuskegee Institute, United States · NIH-11621787

  • Predicting how antimalarial drug resistance spreads with AI

    A powerful AI model will be built to forecast how resistance to antimalarial drugs might spread in Africa and beyond, helping clinicians and public health teams stay ahead of outbreaks.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11610185

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.